Technavio
Announces the Publication of its Research Report Global Alopecia Drugs Market
2016-2020
Technavio recognizes the following companies as the key players in the global alopecia drugs market: GlaxoSmithKline, Johnson & Johnson, and Merck
Other Prominent Vendors in the market are: Aclaris Therapeutics, Actelion Pharmaceuticals, Almirall, AndroScience, Anterios, Aqua Pharmaceuticals, Astellas Pharma, Bayer HealthCare, BERG Health, BiologicsMD, BioPharmX, Celtaxsys, Cipher Pharmaceuticals, Concert Pharmaceuticals, Cosmo Pharmaceuticals, Dermira, Elorac, F. Hoffmann-La Roche, Foamix, Guthy-Renker, Helix BioMedix, Hygeia Therapeutics, Hyundai Pharm, Incyte, Kasiak Research, Kythera Biopharmaceuticals, Mylan, NovaLead Pharma, Novan, Oculus Innovative Sciences, Paratek Pharmaceuticals, Photocure, Polichem, Promius Pharma, Ranbaxy Laboratories, Reckitt Benckiser, Regience, Samumed, RepliCel, Skinvisible Pharmaceuticals, Teva Pharmaceutical, Versapharm, and XBiotech
Commenting on the report, an analyst from Technavios team said: The use of regenerative medicine is an emerging treatment option for the treatment of alopecia. These regenerative medicines help in the healing process by replacement or regeneration of the human cells, tissues or organs, and thus assist in establishing the normal function. Cell therapy and growth factor therapy are some of the regenerative techniques included in the treatment of alopecia. Companies such as RepliCel, Kyocera, and RIKEN Organ Technologies. are engaged in the development of regenerative medicines for the treatment of alopecia. Apart from these companies, various research organizations such as Mayo Clinic, Center for Regenerative Medicine are also engaged in the development of regenerative medicines.”
Technavio recognizes the following companies as the key players in the global alopecia drugs market: GlaxoSmithKline, Johnson & Johnson, and Merck
Other Prominent Vendors in the market are: Aclaris Therapeutics, Actelion Pharmaceuticals, Almirall, AndroScience, Anterios, Aqua Pharmaceuticals, Astellas Pharma, Bayer HealthCare, BERG Health, BiologicsMD, BioPharmX, Celtaxsys, Cipher Pharmaceuticals, Concert Pharmaceuticals, Cosmo Pharmaceuticals, Dermira, Elorac, F. Hoffmann-La Roche, Foamix, Guthy-Renker, Helix BioMedix, Hygeia Therapeutics, Hyundai Pharm, Incyte, Kasiak Research, Kythera Biopharmaceuticals, Mylan, NovaLead Pharma, Novan, Oculus Innovative Sciences, Paratek Pharmaceuticals, Photocure, Polichem, Promius Pharma, Ranbaxy Laboratories, Reckitt Benckiser, Regience, Samumed, RepliCel, Skinvisible Pharmaceuticals, Teva Pharmaceutical, Versapharm, and XBiotech
Commenting on the report, an analyst from Technavios team said: The use of regenerative medicine is an emerging treatment option for the treatment of alopecia. These regenerative medicines help in the healing process by replacement or regeneration of the human cells, tissues or organs, and thus assist in establishing the normal function. Cell therapy and growth factor therapy are some of the regenerative techniques included in the treatment of alopecia. Companies such as RepliCel, Kyocera, and RIKEN Organ Technologies. are engaged in the development of regenerative medicines for the treatment of alopecia. Apart from these companies, various research organizations such as Mayo Clinic, Center for Regenerative Medicine are also engaged in the development of regenerative medicines.”
Know more about sample report: https://marketreportscenter.com/reports/470080/global-alopecia-drugs-market-2016-2020#
According to
the report, the alopecia market has a huge unmet need in terms of approved
therapies. Globally, the market has only two approved drugs, one (minoxidil)
being topical in nature whereas, other (finasteride) being oral. However, these
two drugs have a huge success story with the individuals affected with alopecia
and command nearly 80% of the market share. Lately, the Japanese, South Korean,
and Australian market have seen the entry of AVODART, impact of which is yet to
be quantified by the market. However, considering the efficacy and safety of
this drug, once approved for the US and the EU market, the alopecia drug market
should witness stronger growth on a global scale.
Further, the report states that the increasing incidence of alopecia worldwide is providing a perfect growth platform to the market. However, as currently, the market has only one approved therapy, there is a huge unmet need to be addressed. Additionally, considering the complex etiology of alopecia and its idiopathic occurrence, the development of any new formula is always in dispute. Several theories exist regarding the pathogenesis of the disease, including being labeled as an autoimmune disorder caused by genetic mutation; however, none of the theories provided exact pathophysiology of alopecia. This further restrains the prospects of new therapies coming into the market. Additional factors such as hormonal disorders and environmental-related issues like pollution play an important role in developing this disease.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Further, the report states that the increasing incidence of alopecia worldwide is providing a perfect growth platform to the market. However, as currently, the market has only one approved therapy, there is a huge unmet need to be addressed. Additionally, considering the complex etiology of alopecia and its idiopathic occurrence, the development of any new formula is always in dispute. Several theories exist regarding the pathogenesis of the disease, including being labeled as an autoimmune disorder caused by genetic mutation; however, none of the theories provided exact pathophysiology of alopecia. This further restrains the prospects of new therapies coming into the market. Additional factors such as hormonal disorders and environmental-related issues like pollution play an important role in developing this disease.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
About Alopecia Drugs
Alopecia is a loss of hair and can occur at any age across the genders. The exact cause of this disorder is unknown, but many factors are assumed to be responsible for developing alopecia. Few of the primary ones are a sedentary lifestyle, unhealthy diets, and side effects of certain medical treatments. Moreover, hormonal imbalance and aging increase the probability of developing a chronic disease like cancer, arthritis, depression, and hypertension, which would also lead to hair loss, especially among middle-to-late-aged people.
Technavio’s analysts forecast the global alopecia drugs market to grow at a CAGR of 5.02% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global alopecia drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of alopecia drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Alopecia Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GlaxoSmithKline
• Johnson & Johnson
• Merck
Other prominent vendors
• Aclaris Therapeutics
• Actelion Pharmaceuticals
• Almirall
• AndroScience
• Anterios
• Aqua Pharmaceuticals
• Astellas Pharma
• Bayer HealthCare
• BERG Health
• BiologicsMD
• BioPharmX
• Celtaxsys
• Cipher Pharmaceuticals
• Concert Pharmaceuticals
• Cosmo Pharmaceuticals
• Dermira
• Elorac
• F. Hoffmann-La Roche
• Foamix
• Guthy-Renker
• Helix BioMedix
• Hygeia Therapeutics
• Hyundai Pharm
• Incyte
• Kasiak Research
• Kythera Biopharmaceuticals
• Mylan
• NovaLead Pharma
• Novan
• Oculus Innovative Sciences
• Paratek Pharmaceuticals
• Photocure
• Polichem
• Promius Pharma
• Ranbaxy Laboratories
• Reckitt Benckiser
• Regience
• Samumed
• RepliCel
• Skinvisible Pharmaceuticals
• Teva Pharmaceutical
• Versapharm
• XBiotech
Market driver
• Popularity of off-label and OTC drugs
• For a full, detailed list, view our report
Market challenge
• Limited availability of approved drugs
• For a full, detailed list, view our report
Market trend
• Emergence of laser technology and platelet-rich plasma (PRP) therapy
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Table
of content: https://marketreportscenter.com/reports/470080/global-alopecia-drugs-market-2016-2020#toc
About
Us:
Market Reports Center is an e-commerce
platform obliging the needs of knowledge workers, experts, professionals who
are subject to market research information for their work, or to make strategic
business decisions. Market Reports Center’s team consistently works to update
and extend our existing repository of market research reports by partnering
with new publishers and adding their studies to our website.
Contact us for more details:
Sam
Collins
Market Reports Center
Phone
No: 1-646-883-3044 (US)
No comments:
Post a Comment